The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

There has been long-standing interest in the use of incentives to encourage delivery of high-quality health care services at the lowest feasible cost. Although it is clear that health care ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

In this report, we explore the status of access and uptake for NGS testing for lung cancer in Europe, develop the health economic case for NGS testing, and identify barriers and opportunities for ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

Across the globe, drug shortages are becoming increasingly common. Key takeaways Drug shortages are a growing global concern, affecting multiple therapeutic areas. Shortages are often concentrated in ...

Among the significant measures introduced by the Act, including action on clean energy and climate change, the IRA introduces – for the first time – provisions to reduce federal spending on medicines.

We conducted a quantitative preference study to understand how well the criteria of NICE’s severity modifier align with UK societal preferences. Our primary objectives were to estimate: Cut-offs for ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...

Today marks Rare Disease Day 2025. This time last year we published an Article entitled “ Why do we care about rare? ”, summarising the origins of rare disease day, the fundamental ambition – to ...